The results could open the door to new targeted therapies for this debilitating disease in the future
In the largest study of its kind, nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study, published today (19 March) in Nature Genetics, could open the door to new targeted therapies for this debilitating disease in the future.
Almost nine million people in the UK suffer from osteoarthritis, a degenerative joint disease in which a person’s joints become damaged, stop moving freely and become painful. Osteoarthritis is the most prevalent musculoskeletal disease and a leading cause of disability worldwide.
There is no treatment for osteoarthritis. The disease is managed with pain relief and culminates in joint replacement surgery, which has variable outcomes.
In the largest study of its kind, scientists from the Wellcome Sanger Institute and their collaborators* investigated the genetics behind osteoarthritis, as well as the diseases and traits that are linked to it.
To understand more about the genetic basis of osteoarthritis, the team studied 16.5 million DNA variations from the UK Biobank resource. Following combined analysis in up to 30,727 people with osteoarthritis and nearly 300,000 people without osteoarthritis in total – the controls – scientists discovered nine new genes that were associated with osteoarthritis, a significant result for this disease.
“Osteoarthritis is challenging to study because the disease can vary among people, and also between the different joints affected, for example knee, hip, hand and spine. Using data from the UK Biobank resource, we have undertaken the largest genetic study of osteoarthritis to date and uncovered nine new genes associated with the disease.”
Professor Eleftheria Zeggini, senior author from the Wellcome Sanger Institute
Researchers then investigated the role of the nine new genes in osteoarthritis, by studying both normal cartilage and diseased cartilage from individuals who had a joint replacement.
The team looked for genes that were active in the progression of the disease by extracting the relevant cells from healthy and diseased tissue, studying the levels of proteins in the tissue and sequencing the RNA – the messenger that carries instructions from DNA for controlling the production of proteins.
Of the nine genes associated with osteoarthritis, researchers identified five genes in particular that differed significantly in their expression in healthy and diseased tissue. The five genes present novel targets for future research into therapies.
“These results are an important step towards understanding the genetic causes of osteoarthritis and take us closer to uncovering the mechanism behind the disease. Once we know that, it opens the door to developing new therapies for this debilitating disease.”
Ms Eleni Zengini, joint first author from the University of Sheffield and Dromokaiteio Psychiatric Hospital in Athens
The team also explored genetic correlations between osteoarthritis and obesity, bone mineral density, type 2 diabetes, and raised blood lipid levels.
Researchers applied a statistical technique known as causal inference analysis to uncover which traits and diseases cause osteoarthritis, and which do not.
Within the limits of their study, scientists discovered that type 2 diabetes and high levels of lipids in the blood do not have causal effects on osteoarthritis, but reaffirm that obesity does.
“Using genetic data, we have shown that type 2 diabetes and increased blood lipid levels do not appear to be on the causal path to osteoarthritis. We also reconfirmed that obesity is on the causal path to osteoarthritis.”
Dr Konstantinos Hatzikotoulas, joint first author from the Wellcome Sanger Institute
“The discovery of these genes is positive news for the 8.5 million people in the UK living with osteoarthritis. People living with this debilitating condition currently have limited treatment options. Meanwhile, they can struggle to do the day-to-day things most of us take for granted, like going to work or getting dressed independently. By revealing how these genes contribute to osteoarthritis, this research could open the door for new treatments to help millions of people live the pain free life they deserve.”
Dr Natalie Carter, Head of research liaison & evaluation at Arthritis Research UK, who did not fund the study
Learn more: New osteoarthritis genes discovered
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- Do soft drinks affect women's bone health?on November 29, 2019 at 8:44 am
Share on Pinterest Does soda impact bone health? A recent study adds to the evidence. Osteoarthritis, which is characterized by progressively weak and brittle bones, predominantly affects older adults ...
- With CAGR of 7.6%, Osteoarthritis Treatment Market Analyse by Size, Share, Trends and Revenue Analysison November 29, 2019 at 2:10 am
Nov 29, 2019 (AmericaNewsHour) -- Osteoarthritis is a long-term chronic disease which occurs due to deterioration of cartilaginous muscles in joints and increases pain and stiffness in bone joint in ...
- Arthritis Research Canada - Preventing Knee Osteoarthritis In Youth Who Play Sportson November 27, 2019 at 11:06 am
Millions of Canadians currently live with the pain and disability of osteoarthritis (OA), a disabling joint condition. It is estimated that by 2040, 25% of all Canadians will have OA. This percentage ...
- TLC Announces First Patient Enrollment in EXCELLENCE Trial Evaluating Single and Repeat Administrations of TLC599on November 27, 2019 at 3:41 am
Phase III clinical trial of TLC599 to recruit 500 patients with moderate to severe symptomatic knee osteoarthritis -- Patients can receive two injections of placebo or drug -- Patient enrollment ...
- Lorecivivint yields improved patient-reported outcome scores in knee OAon November 27, 2019 at 2:41 am
Yusuf Yacizi, MD, of the department of rheumatology at the New York University Langone Medical Center, and colleagues conducted a post-hoc analysis of lorecivivint compared with placebo in a 24-week ...
- Global Osteoarthritis Treatment Market Expected to Flourish at a Significant CAGR of 7.6% By 2027on November 26, 2019 at 3:58 am
Nov 26, 2019 (AmericaNewsHour) -- The global osteoarthritis treatment market is segmented into medications such as acetaminophen and non-steroidal anti-inflammatory. Among these segments, ...
- Sr/PTA Metal Organic Framework as A Drug Delivery System for Osteoarthritis Treatmenton November 26, 2019 at 3:03 am
A Sr-based metal-organic framework (MOF) is introduced as ketoprofen carrier to form a comprehensive system for treating osteoarthritis (OA), and the drug loading amount and release rate is ...
- Research opens the door to better understanding of osteoarthritison November 25, 2019 at 1:54 pm
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly ...
- Visualization and quantification of the degenerative pattern of the talus in unilateral varus ankle osteoarthritison November 25, 2019 at 2:15 am
The aim of this study was to quantify and visualize the degenerative patterns of the talus in ankle osteoarthritis (OA). The differences in talar morphology between sides of patients with unilateral ...
via Bing News